Cardinal Health 200 recalled Salem Sump PVC gastroduodenal tubes on September 18, 2025. The recall affects all lots sold worldwide due to complaints of Anti-Reflux Valve breakage. Patients and healthcare providers must stop using the devices immediately.
Firm has received complaints regarding Anti-Reflux Valve (ARV) breakage due to excessive force during use. Firm is providing additional guidance for use. Expansion of RES 95214.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Cardinal Health 200, LLC or your healthcare provider for instructions. Notification method: Letter
The recall includes various Salem Sump PVC and polyurethane gastroduodenal tubes in multiple sizes. The affected product codes include 1180264408, 1180264416, 1180264424, 1180264432, 1180264440, 1180264457, 1180264523, 1180264531, 1180264549, 1180264556, and 1180264895. These products were distributed worldwide.
The firm received complaints concerning the breakage of the Anti-Reflux Valve (ARV) when excessive force is applied during use. This poses a high risk of improper function leading to complications in patients.
While the exact number of incidents is not disclosed, complaints regarding ARV breakage have prompted this urgent recall. There are no reported injuries or deaths associated with this issue.
Patients and healthcare providers should stop using the affected tubes immediately and follow the recall instructions provided by Cardinal Health. Contact the company or your healthcare provider for guidance.
For more information, contact Cardinal Health at [insert phone number] or visit their website [insert URL].
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.